The European Medicines Agency (EMA) has released a new general guidance document on the development of medicinal products intended to treat asthma, a condition that restricts a patient's airways and can be fatal if improperly treated.
Background and Overview
The document, Draft note for guidance on clinical investigation of medicinal products for treatment of asthma, is meant to provide general advice on the development of asthma products, including clinical development programs
EMA Releases Draft Guidance on Development of Asthma Medications
No comments:
Post a Comment